Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL)

Price 3.55p on 29-03-2024 at 04:45:11
Change 0.00p 0%
Buy 3.60p
Sell 3.50p
Buy / Sell VAL Shares
Last Trade: Buy 20,000.00 at 3.585p
Day's Volume: 0
Last Close: 3.55p
Open: 0.00p
ISIN: GB00BLH13C52
Day's Range 0.00p - 0.00p
52wk Range: 3.55p - 14.75p
Market Capitalisation: £5m
VWAP: 0.00p
Shares in Issue: 132m

Recent Trades History ValiRx (VAL)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 20,000 3.585p Ordinary
16:19:20 - 28-Mar-24
Unknown* 13,380 3.55p Ordinary
16:15:52 - 28-Mar-24
Unknown* 36,000 3.55p Ordinary
16:05:13 - 28-Mar-24
Sell* 60,340 3.505p Ordinary
16:02:18 - 28-Mar-24
Buy* 250,000 3.59p Ordinary
16:01:50 - 28-Mar-24
Sell* 7,704 3.5038p Ordinary
14:47:33 - 28-Mar-24
Buy* 6,544 3.6375p Ordinary
14:41:42 - 28-Mar-24
Sell* 4,775 3.51p Ordinary
12:56:15 - 28-Mar-24
Sell* 75,419 3.50p Ordinary
12:15:28 - 28-Mar-24
Sell* 57,088 3.52p Ordinary
10:50:53 - 28-Mar-24

Share Price History for ValiRx

Time period:
to
Date Open High Low Close Volume

Share News for ValiRx

ValiRx inks evaluation deal with Imperial College London for research

21st Mar 2024 11:22

(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeutic candidates for cancer treatment. Read More

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

19th Mar 2024 19:47

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

ValiRx says requisition notice from shareholder group is invalid

13th Feb 2024 14:45

(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following legal advice. Read More

IN BRIEF: ValiRx signs research sharing deal with Dundee University

12th Feb 2024 11:42

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug discovery unit to access research concerning novel therapeutic candidates. The agreement will be active for a period of five years, in which ValiRx may review research projects from the unit in areas aligned with the company's focus on cancer therapeutics. Read More

TRADING UPDATES: ValiRx receives shareholder request for board change

9th Feb 2024 20:24

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

FTSE 100 Latest
Value7,952.62
Change0.00

Login to your account

Forgot Password?

Not Registered